FLUID Logo

Objective medication adherence for enhanced cardiovascular disease and risk control.

Cardiovascular Disease is the Leading Cause of Death in the U.S.

  • Complete Care

    50% of hypertensive patients are non-adherent to their cardiovascular medications.


    Source: Abegaz MA, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Jan; 96(4): e5641.

  • Be Certain

    125,000 preventable deaths per year related to nonadherence.


    Source: http://bemedicinesmart.org. National Council on Patient Information and Education. Accelerating Progress in Prescription Medicine Adherence: The Adherence Action Agenda. A National Action Plan to Address America’s “Other Drug Problem.” Updated: October 2013. Viewed: January 5, 2018.

  • Protection for Tomorrow

    Adherence to therapy can reduce risk of all-cause mortality by up to 60%.


    Source: Abegaz MA, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Jan; 96(4): e5641.

How do you know if your patients are taking their cardiovascular (CV) medications as prescribed?

KardiAssure is a convenient, accurate, objective evaluation of Medication Adherence. Providing the critical missing piece in achieving better control of cardiovascular disease (CVD) and its associated risk factors and complications.

KardiAssure provides insight at hand through the delivery of reliable and objective data that can help tailor treatment plans and improve outcomes.

  • Complete Care

    PRECISE
    Direct analysis of biological fluids is the most accurate method for evaluating adherence.

  • Be Certain

    COMPREHENSIVE
    Detects 50+ relevant medications across the three major CV conditions (hypertension, coronary artery disease, heart failure).

  • Protection for Tomorrow

    EASY
    Non-invasive, in-office collection and lab-based urinalysis with an integrated support team that simplifies performing test and interpreting results.

More Than a Test

  • Pharm.D.s available for clinical consultation provide more resources when you need it.
  • Overnight specimen transportation and fast turnaround time deliver consistent results for more informed decisions.
  • Local Regional Sales Managers and dedicated Inside Sales contacts provide more support for your practice.
  • Capable of objectively assessing multiple CV medications.
  • Aegis FLUID™ electronic connectivity solutions deliver more options to integrate into your digital patient workflow.
  • Provides an objective measure of success in controlling patients’ hypertension (HTN); useful for MACRA review and other quality measures such as MIPS.

Want to learn more?

Want to learn more?

To learn more or begin testing, please contact our Client Services team at:

1.800.533.7052